Media headlines about Streamline Health Solutions (NASDAQ:STRM) have been trending somewhat positive recently, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Streamline Health Solutions earned a news impact score of 0.17 on Accern’s scale. Accern also gave news articles about the company an impact score of 47.0368921006658 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Separately, Zacks Investment Research upgraded Streamline Health Solutions from a “hold” rating to a “buy” rating and set a $1.50 price objective on the stock in a research report on Wednesday, September 27th.
Streamline Health Solutions (NASDAQ:STRM) traded down $0.06 during trading on Wednesday, reaching $1.53. The company’s stock had a trading volume of 62,400 shares, compared to its average volume of 120,237. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.75 and a current ratio of 0.75. Streamline Health Solutions has a 1-year low of $0.85 and a 1-year high of $2.82.
Streamline Health Solutions, Inc is engaged in providing healthcare information technology through the licensing of its Electronic Health Information Management, Patient Financial, Coding and Clinical Documentation Improvement (CDI), and other Workflow software applications, and the use of such applications by software as a service.
Receive News & Ratings for Streamline Health Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions and related companies with MarketBeat.com's FREE daily email newsletter.